Health TrialsbyHealthPanel

Long-term Outcomes After Laparoscopic Subtotal and Total Hysterectomy

ConditionHysterectomy
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-65
SponsorUniversity of Palermo

About this trial

Hysterectomy is one of the most commonly performed gynecologic surgeries in the USA. It is used for many benign conditions such as leiomyoma and abnormal uterine bleeding. Surgery may involve the removal of the cervix (total hysterectomy, TH) or its preservation (supracervical or subtotal hysterectomy, SH). Whether TH or SH is the best procedure for benign conditions is a matter of debate. Considering the lack of evidence, this study aims to evaluate long-term sexual dysfunctions, urinary dysfunctions and pelvic organ prolapse in women who underwent laparoscopic subtotal versus total hysterectomy for benign conditions.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Women who underwent subtotal or total hysterectomy by laparoscopy for benign conditions.

Disqualifiers

Women with gynecological and non-gynecological cancers.

Trial population

Women who underwent subtotal or total hysterectomy by laparoscopy for benign conditions

Trial design

Design model

Case-control

Time perspective

Retrospective

Treatments tested in this trial

  • Subtotal Laparoscopic Hysterectomy

    Procedure/Surgery

    Subtotal laparoscopic hysterectomy involves removing the main body of the uterus and leaving the cervix in place by laparoscopy.

  • Total Laparoscopic Hysterectomy

    Procedure/Surgery

    Total laparoscopic hysterectomy involves removing the whole uterus and cervix by laparoscopy

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: Subtotal Laparoscopic Hysterectomy1 intervention
Group B: Total Laparoscopic Hysterectomy1 intervention

Trial outcomes

Primary outcomes

1

Sexual Dysfunctions

Female Sexual Function Index

Time frame
5 years after surgery

Secondary outcomes

1

Urinary Dysfunctions

Pelvic Floor Distress Inventory short form

Time frame
5 years after surgery
2

Pelvic Organ Prolapse

Pelvic Organ Prolapse (POP-Q) evaluation

Time frame
5 years after surgery

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Palermo

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: